Order Of Potency Research Articles

Fouling-Resistant Voltammetric Xylazine Sensors for Detection of the Street Drug “Tranq”

As the opioid crisis continues to wreak havoc on a global scale, it is increasingly critical to develop methodologies to detect the most dangerous drugs such as fentanyl and its derivatives, which have orders of magnitude higher potency than morphine. The scientific challenge for chemical detection of fentanyl and its derivatives is complicated by both the constantly increasing synthetic variations of the drug as well as the expanded use of adulterants. One tragically consequential example is the nocuous street drug known as “Tranq”, which combines fentanyl or a fentanyl derivative with the veterinary sedative Rompun®, chemically identified as xylazine (XYL). This pervasive street cocktail is exacerbating the already staggering number of fentanyl-related deaths as its acute toxicity poses a danger to medical first-responders and complicates their initial assessment and treatment options for overdose victims. Given the widespread use of XYL as an adulterant, an electrochemical XYL sensor capable of on-site operation by non-experts as a fast-screening tool is a notable goal. This work presents a voltammetry-based sensor featuring carbon electrodes modified with carboxylic-acid functionalized multi-walled carbon nanotubes layered with cyclodextrin and polyurethane membranes for sensitivity and selectivity enhancements. The sensor has critical and robust fouling resistance while providing sensitivity at 950 μA/mM∙cm2, a low limit of detection (~5 ppm), and the ability to detect XYL in the presence of fentanyl and/or other non-fentanyl stimulants like cocaine. The demonstrated sensor can be applied to promote public health with its ability to detect and indicate XYL in the presence of opioids, serving to protect drug-users, first responders, medical examiners, and on-site forensic investigators from exposure to these dangerous mixtures.

Assessment of pharmacological effects and abuse potential of 5F-EDMB-PICA, CUMYL-PEGACLONE, and NM-2201 in mice.

The newly emerging synthetic cannabinoids (SCs) 5F-EDMB-PICA, CUMYL-PEGACLONE, and NM-2201 have been observed to produce effects by activating cannabinoid type 1 (CB1) receptors. Nevertheless, the pharmacological effects and potential for abuse of these three substances remain to be studied. These substances have yet to be regulated in many countries. We investigated the safety, pharmacological effects, rewarding effects, and cannabinoid withdrawal of 5F-EDMB-PICA, CUMYL-PEGACLONE, and NM-2201. This study evaluated the drug safety and the cannabinoid-specific pharmacological effects of the three substances through acute toxicity experiments (in which the LD50 of each substance was obtained) and tetrad experiments (comprising assessments of hypothermia, analgesia, locomotion inhibition, and catalepsy). Furthermore, the conditioned place preference (CPP) experiments and withdrawal experiments were conducted to evaluate the rewarding effect and cannabinoid withdrawal potential of the substances in question. The results demonstrated that all three drugs exhibited certain acute toxic effects and could potentially induce tetrad effects. The data were analyzed using non-linear regression, and the corresponding ED50 values and 95% confidence intervals (CI) were obtained. The rank order of potency was determined to be CUMYL-PEGACLONE > 5F-EDMB-PICA > NM-2201. In the CPP experiments, it was demonstrated that 5F-EDMB-PICA significantly induced an increase in CPP score at a dose of 0.3mg/kg, while NM-2201 caused an increase in CPP score and a significant aversion effect at a dose of 2 and 3mg/kg, respectively. It is noteworthy that all three types of SCs were observed to produce a significant biphasic effect, indicating that CPP scores were biphasic for all compounds. Following the administration of the CB1 receptor antagonist rimonabant, a notable increase in head twitches and paw tremors was observed, indicating that these three SCs induce cannabinoid withdrawal through the mediation of CB1 receptors. The results of this study indicated that these SCs possess cannabinoid-specific pharmacological effects and abuse potential, which provides substantial experimental data to support the future regulation of these substances.

Evaluation of the sedative-motor effects of novel GABAkine imidazodiazepines using quantitative observation techniques in rhesus monkeys.

Benzodiazepines bind to γ-aminobutyric acid type A (GABAA) receptor subtypes identified by different α subunits (i.e., α1GABAA, α2GABAA, α3GABAA, and α5GABAA). Sedative-motor effects of benzodiazepines are thought to involve α1GABAA and α3GABAA subtypes. We evaluated observable measures of sedative-motor effects and species-typical behaviors in monkeys following acute administration of novel GABAkines (positive allosteric modulators of GABAA receptors), with varying degrees of selective efficacy at different GABAA receptor subtypes. We predicted that the induction of sedative-motor effects would depend on the degree of α1GABAA and α3GABAA efficacy. Adult female rhesus monkeys (N = 4) were implanted with chronic indwelling i.v. catheters. Quantitative behavioral observation was conducted by trained observers following administration of multiple doses of the conventional benzodiazepine alprazolam and the GABAkines MP-III-80 (preferential efficacy at α2/α3/α5GABAA subtypes), KRM-II-81, MP-III-24 (both with preferential efficacy for α2/α3GABAA subtypes), and MP-III-22 (preferential potency and efficacy for α5GABAA subtypes). As with alprazolam, all GABAkines induced significant levels of mild sedation ("rest/sleep posture"). Deep sedation was observed with alprazolam, MP-III-80, and MP-III-22; motoric effects (observable ataxia) were obtained with alprazolam, KRM-II-81, and MP-III-22 only. Surprisingly, the order of potency for rest/sleep posture was significantly associated only with potency at α5GABAA subtypes. GABAkines with preferential efficacy at α2/α3GABAA and/or α5GABAA subtypes engendered sedative-motor effects in monkeys, although only compounds with α5GABAA activity engendered deep sedation. Moreover, the significant relationship between potency obtained with in vitro electrophysiology data and the rest/sleep posture measure suggests a role for the α5GABAA subtype in this milder form of sedation.

Exploring the nutritional biochemical profiles and biological functions in the green microalga <i>Chlorella fusca</i>

<i>Chlorella</i> species of microalgae are utilized in the crop and food industries. The aim of this research was to investigate the metabolite profiles of <i>Chlorella fusca</i> for the first time and evaluate its biological properties. The two ion modes of UPLC-Q-TOF-MS/MS were used to identify a total of 62 components in the methanol extract of <i>C. fusca</i>, with 26 in the negative and 36 in the positive ion mode, including 10 identical ingredients. Fatty acids (negative mode) and combinations of chlorophyll and fatty acids (positive mode) were the most prevalent chemical structures, constituting over 80 and 70% of the total metabolites, respectively, followed by chlorophyll, polar lipids, carotenoids, and fatty alcohols. Moreover, this extract exhibited potent antioxidant and anti-aging benefits in decreasing order of potency at a concentration of 200 μg mL<sup>-1</sup>: tyrosinase inhibition (100%), ABTS radical scavenging (90%), elastase inhibition (88%), and DPPH radical scavenging (34%). Notably, this extract protected the mobility of DNA fragments up to 5 μg mL<sup>-1</sup> (26%), with potential effects (> 60% at 200 μg mL<sup>-1</sup>). These findings suggest that <i>C. fusca</i> may be a promising candidate for applications related to its biological functions, owing to the high accumulation of fatty acids and chlorophyll derivatives.

Effect of water Resource utilization in Poyang lake area on carbon emissions based on decoupling theory

The utilization of regional water resources has the potential to impact carbon emissions. Maintaining a decoupled relationship between water resources and carbon emissions facilitates harmonious regional development. Understanding the mechanism of their coordination is conducive to achieving the "Double Carbon" goal and control of regional carbon emissions and water resource consumption. This study examines the decoupling relationship between water resource utilization and carbon emissions in Poyang Lake area, China, employing the Tapio decoupling model and the LMDI(logarithmic mean divisia index) decomposition model. The results indicate that carbon emissions in Poyang Lake area exhibited a gradual increase, accompanied by an annual growth rate of 5.99 %. The water supply exhibited a slow expansion. They have exhibited state of affairs strong negative decoupling and expansive negative decoupling over the past 15 years. Moreover, this situation is most acute and worsening in the secondary industry. The water use structure effect and water economic benefit effect are the primary factors affecting carbon emission increases, contributing 57.93 % and 65.66 %, respectively. Carbon emissions intensity is the largest inhibiting factor, which accounts for a maximum contribution of 42.96 %. The order of potency of the driving factors is as follows: water economic benefit > carbon emission intensity > water use structure > water use efficiency. In summary, this research recognised the enhancement of the water economic efficiency index not only facilitates the decoupling phenomenon but also improves the water-carbon relationship, especially in the secondary industry. It serves as a compelling illustration of the significance of elucidating the interrelationship between regional water and carbon dynamics, and charting the course for the formulation of regional policies that would facilitate the advancement of environmentally conscious and carbon-neutral development, as well as water conservation.

Effects of Polyphenols and Lignans of Phyllanthus amarus Schumach. and Thonn. on IL-1β and TNF-α Secretions from LPS-induced THP-1-derived Macrophages

Background: Phyllanthus amarus exhibited immunosuppressive and anti-inflammatory effects in several in vitro and in vivo studies. However, there is no report on the inhibitory effects of its secondary metabolites on pro-inflammatory cytokines secretion from human THP-1-derived macrophages. background: Phyllanthus amarus exhibited immunosuppressive and anti-inflammatory effects in several in vitro and in vivo studies. However, there is no report on the inhibitory effects of its secondary metabolites on pro-inflammatory cytokines secretion from human THP-1-derived macrophages. Objective: The objective of this study was to correlate the polyphenols (ellagic acid (EA), gallic acid (GA), geraniin (GER), and corilagin (COR)) and lignans ((phyllanthin (PHY), hypophyllanthin (HYPO), niranthin (NIR), phyltetralin (PHYLT), and isolintetralin (ISO)) of 80% ethanol extract of P. amarus with their inhibitory effect against IL-1β and TNF-α secretions from LPS-induced THP-1- derived macrophages. Methods: Chemical profiling of P. amarus was carried out by LC-MS/MS analysis. Validated qualitative and quantitative reversed-phase HPLC analyses of the P. amarus extract were performed for the determination of lignan and polyphenol contents. Human THP-1-derived macrophages were prepared by treatment of THP-1 cells with phorbol 12-myristate 13-acetate (PMA). The inhibition of cytokines released by the extract, lignans and polyphenols in the cells was investigated using ELISA assay. method: Chemical profiling of P. amarus was carried out by LC-MS/MS analysis. Validated qualitative and quantitative reversed phase HPLC analyses of the P. amarus extract were performed for determination of lignan and polyphenol contents. Human THP-1 derived macrophages were prepared by treatment of THP-1 cells with phorbol 12-myristate 13-acetate (PMA). The inhibition of cytokines release by the extract, lignans and polyphenols in the cells were investigated using ELISA assay. Results: P. amarus extract and its chemical constituents significantly reduced the levels of IL-1β and TNF-α in a dose-dependent manner. At a dose of 50 μM, COR exhibited a maximum inhibition of 81.11% on TNF-α secretion, while GER showed 72.56% inhibition on IL-1β secretion. COR demonstrated the strongest inhibition of TNF-α secretion, exhibiting an IC50 value of 9.06 μM, which was comparable to that of dexamethasone (7.07 μM). Meanwhile, GER was the most potent against IL- 1β secretion, exhibiting an IC50 value of 20.09 μM. In the case of TNF-α secretion, the order of potency observed among the active compounds, with regard to IC50 value, was COR > GER > HYPO > PHY > NIR > GA > EA >ISO > PHYLT. For IL-1β secretion, the order of potency was GER > NIR > COR > GA > EA > PHY > HYPO > PHYLT > 1SO. Conclusion: The polyphenol contents of P. amarus, especially COR and GER, contributed significantly to the suppression of cytokines secretion, and they have the potential to be developed into agents for the treatment of pathologic inflammation.

Pharmacological differences between human and mouse P2X4 receptor explored using old and new tools.

There is growing interest in the P2X4 receptor as a therapeutic target for several cardiovascular, inflammatory and neurological conditions. Key to exploring the physiological and pathophysiological roles of P2X4 is access to selective compounds to probe function in cells, tissues and animal models. There has been a recent growth in selective antagonists for P2X4, though agonist selectivity is less well studied. As there are some known pharmacological differences between P2X receptors from different species, it is important to understand these differences when designing a pharmacological strategy to probe P2X4 function in human tissue and mouse models. Here, we provide a systematic comparison of agonist and antagonist pharmacology in 1321N1 cells expressing either human or mouse P2X4 orthologues. We identify a rank order of agonist potency of ATP > 2-MeSATP > αβmeATP = BzATP > CTP = γ-[(propargyl)-imido]-ATP for human P2X4 and ATP > 2-MeSATP = CTP > ATPγS = γ-[(propargyl)-imido]-ATP = BzATP for mouse. Human P2X4 is not activated by ATPγS but can be activated by αβmeATP. We identify a rank order of antagonist potency of BAY-1797 = PSB-12062 = BX-430 > 5-BDBD > TNP-ATP = PPADS for human P2X4 and BAY-1797 > PSB-12062 = PPADS > TNP-ATP for mouse. Mouse P2X4 is not antagonised by 5-BDBD or BX-430. The study reveals key pharmacological differences between human and mouse P2X4, highlighting caution when selecting tools for comparative studies between human and mouse and ascribing cellular responses of some commonly used agonists to P2X4.

Relaxant Effects of Curcuma aeruginosa Rhizome Extracts on Isolated Rat Gastric Fundus and Ileum Contraction

Curcuma aeruginosa (CA) rhizomes are used in traditional medicine as gastrointestinal remedies, postpartum care and uterine issues. However, its effects on gastrointestinal motility have not yet been explored. Extracts of CA rhizomes prepared using chloroform, methanol and water were evaluated for their effects on gastrointestinal contractions using isolated rat gastric fundus and ileum. Varied solvents aim for extraction of different compounds of CA rhizome. In the ileum, the 3 extracts did not significantly affect spontaneous contractions, but significantly reduced contractions induced by acetylcholine (ACh, 0.3 µM) and KCl (40 mM) in a concentration-dependent manner. The order of potency, based on ACh-induced contraction, was chloroform > methanol > water extracts, with respective IC50 values of 0.025 ± 0.001, 0.46 ± 0.02 and 2.57 ± 0.47 mg/mL. Similar potency order against KCl-induced contraction was observed, with IC50 values of 0.011 ± 0.002, 0.47 ± 0.06 and 1.18 ± 0.18 mg/mL, respectively. In the isolated gastric fundus model, both methanol and water extracts resulted in an increase in the force of contraction in the absence of stimulation. However, when ACh (0.3 µM) was introduced, the methanol and water extracts exhibited a concentration-dependent reduction in contractions, with IC50 values of 0.62 ± 0.06 and 2.30 ± 0.32 mg/mL, respectively. As for KCl (40 mM)-induced contraction, only the highest concentration of the water extract (3.75 mg/mL) significantly decreased the contraction by 41.29 ± 2.94 %. CA extract demonstrated relaxant effects on both isolated rat gastric fundus and ileal contractions induced by ACh and KCl. These findings support the use of CA in traditional medicine as a gastrointestinal remedy. These extracts have the potential to be used as antispasmodics and to treat infectious and non-infectious diarrhea, the latter of which occurs in functional gastrointestinal diseases. It might also be useful as a gastroprokinetic. HIGHLIGHTS C. aeruginosa extracts had no impact on rat ileum’s spontaneous contraction Extracts caused dose-dependent relaxation of precontracted ileum Extracts enhanced spontaneous contraction of isolated gastric fundus Extracts induced relaxation in the precontracted isolated gastric fundus GRAPHICAL ABSTRACT

Assessment of the potential structure and nucleation efficacy of multi-component heterogeneous substrate

In recent years, nucleation of multi-component heterogeneous interface structures has attracted increasing attention due to their excellent grain refinement and anti-poisoning capabilities in Al-Si alloy. In this research, a general methodology was proposed to predict the surface structure and meanwhile evaluate the grain refinement efficacy of the multi-component boride nucleants based on a comprehensive experimental and theoretical study of a novel Al-Si alloy refiner, i.e., Al-3.5 Nb-1 V-1B. By using high-resolution electron microscopy, the (Nb, V)B2 particle with a characteristic “core-shell” surface structure was observed, attributed to V adsorption driven by interfacial energy minimization, validated by ab initio calculations. A general interfacial energy-based model was then proposed which predicts the multi-component boride substrate structure, well consistent with the experimental findings. The nucleation potency of different substrates was analyzed in atomic scale and only if the interfacial atomic vibration was considered together with the nucleation-influencing factors (i.e., the lattice mismatch and the anti Si-poisoning effect), the predicted nucleation potency order can agree well with the experimental results. A thermodynamics-kinetics combined analytic model was summarized by coupling the lattice mismatch parameter, the interfacial Si adsorption energy and the interfacial atomic vibration amplitude, which accurately evaluates the multi-component boride grain refiners for the Al-Si alloys.

Vasorelaxant Activity of (2S)-Sakuranetin and Other Flavonoids Isolated from the Green Propolis of the Caatinga Mimosa tenuiflora.

Some in vitro and in vivo evidence is consistent with the cardiovascular beneficial activity of propolis. As the single actors responsible for this effect have never been identified, an in-depth investigation of flavonoids isolated from the green propolis of the Caatinga Mimosa tenuiflora was performed and their mechanism of action was described. A comprehensive electrophysiology, functional, and molecular docking approach was applied. Most flavanones and flavones were effective CaV1.2 channel blockers with a potency order of (2S)-sakuranetin > eriodictyol-7,3'-methyl ether > quercetin 3-methyl ether > 5,4'-dihydroxy-6,7-dimethoxyflavanone > santin > axillarin > penduletin > kumatakenin, ermanin and viscosine being weak or modest stimulators. Except for eriodictyol 5-O-methyl ether, all the flavonoids were also effective spasmolytic agents of vascular rings, kumatakenin and viscosine also showing an endothelium-dependent activity. (2S)-Sakuranetin also stimulated KCa1.1 channels both in single myocytes and vascular rings. In silico analysis provided interesting insights into the mode of action of (2S)-sakuranetin within both CaV1.2 and KCa1.1 channels. The green propolis of the Caatinga Mimosa tenuiflora is a valuable source of multi-target vasoactive flavonoids: this evidence reinforces its nutraceutical value in the cardiovascular disease prevention arena.

Characteristics of α1-adrenoceptor antagonists-induced ejaculatory dysfunction on spontaneous seminal emission in rats.

Although α1-adrenoceptor (α1-AR) antagonists used to treat benign prostatic hyperplasia can cause ejaculation disorders, the aetiology of this adverse event is still controversial. Therefore, we investigated the effects of antagonists with different affinities for α1-AR subtypes on ejaculatory function and their mechanisms of action in normal rats. In the spontaneous seminal emission (SSE) test, systemically administered prazosin, terazosin, tamsulosin and naftopidil decreased the weight of ejaculated seminal material in a dose-dependent manner; the potency order was as follows: tamsulosin > terazosin > prazosin > naftopidil. The selective α1D-AR antagonist BMY7378 had no effect on SSE. Intrathecal tamsulosin and naftopidil did not inhibit SSE. Tamsulosin, the most potent, was ineffective as a single dose and significantly increased seminal vesicle fluid in rats treated for 2weeks but did not significantly change retrograde ejaculation. These results indicated that the difference in inhibitory potency of the five α1-AR antagonists against SSE was due to the involvement of α1A-AR subtypes. Our results further suggested that α1-AR antagonist-induced ejaculatory dysfunction at the peripheral level was mainly due to the loss of seminal emission, although some retrograde ejaculation may also be involved.

Comparison of the µ-opioid receptor antagonists methocinnamox (MCAM) and naloxone to reverse and prevent the ventilatory depressant effects of fentanyl, carfentanil, 3-methylfentanyl, and heroin in male rats.

The number of opioid overdose deaths has increased significantly over the past decade. The life-threatening effect of opioids is hypoventilation that can be reversed by the µ-opioid receptor (MOR) antagonist naloxone; however, because of the very short duration of action of naloxone, re-emergence of MOR agonist-induced hypoventilation can occur, requiring additional doses of naloxone. The MOR antagonist methocinnamox (MCAM) antagonizes hypoventilation by the non-morphinan fentanyl and the morphinan heroin in laboratory animals with an unusually long duration of action. Whole-body plethysmography was used to compare the potency and effectiveness of MCAM and naloxone for preventing and reversing hypoventilation by fentanyl, heroin, and the ultra-potent and longer-acting fentanyl analogs carfentanil and 3-methylfentanyl in male rats breathing normal air. Sessions comprised a 45-minute habituation period followed by intravenous (i.v.) administration of saline or an acute dose of MOR agonist. The rank order of potency to decrease ventilation was 3-methylfentanyl > carfentanil > fentanyl > heroin. MCAM (0.0001-0.1 mg/kg) and naloxone (0.0001-0.01 mg/kg) dose-dependently reversed hypoventilation by 3-methylfentanyl (0.01 mg/kg), carfentanil (0.01 mg/kg), fentanyl (0.1 mg/kg), or heroin (3.2 mg/kg). For prevention studies, MCAM, naloxone, or vehicle was administered i.v. 22, 46, or 70 hours prior to a MOR agonist. When administered 22 hours earlier, MCAM (0.1-1.0 mg/kg) but not naloxone (1.0 mg/kg) prevented hypoventilation by each MOR agonist. This study demonstrates the effectiveness of MCAM to reverse and prevent hypoventilation by MOR agonists including ultra-potent fentanyl analogs that have a long duration of action. Significance Statement The number of opioid overdose deaths increased over the past decade despite the availability of antagonists that can prevent and reverse the effects of opioids. This study demonstrates the effectiveness and long duration of action of the µ-opioid receptor (MOR) antagonist methocinnamox (MCAM) for reversing and preventing hypoventilation by MOR agonists including ultra-potent fentanyl analogs. These results provide support for the notion that MCAM has the potential to positively impact the ongoing opioid crisis by reversing and preventing opioid overdose.

Extracellular domain mutations of the EGF receptor differentially modulate high-affinity and low-affinity responses to EGF receptor ligands

The EGF receptor is mutated in a number of cancers. In most cases, the mutations occur in the intracellular tyrosine kinase domain. However, in glioblastomas, many of the mutations are in the extracellular ligand binding domain. To determine what changes in receptor function are induced by such extracellular domain mutations, we analyzed the binding and biological response to the seven different EGF receptor ligands in three common glioblastoma mutants--R84K, A265V, and G574V. Our data indicate that all three mutations significantly increase the binding affinity of all seven ligands. In addition, the mutations increase the potency of all ligands for stimulating receptor autophosphorylation, phospholipase Cγ, Akt, and MAP kinase activity. In all mutants, the rank order of ligand potency seen at the wild-type receptor was retained, suggesting that the receptors still discriminate among the different ligands. However, the low affinity ligands, EPR and EPG, did show larger than average enhancements of potency for stimulating Akt and MAPK, but not receptor autophosphorylation and phospholipase Cγ activation. Relative to the wild-type receptor, these changes lead to an increase in the responsiveness of these mutants to physiological concentrations of ligands and an alteration in the ratio of activation of the different pathways. This may contribute to their oncogenic potential. In the context of recent findings, our data also suggest that so-called ‘high’ affinity biological responses arise from activation by isolated receptor dimers, whereas ‘low’ affinity biological responses require clustering of receptors which occurs at higher concentrations of ligand.

A Surprising Repurposing of Central Nervous System Drugs against Squamous Cell Carcinoma of the Bladder, UM-UC-5.

The potential benefits of drug repurposing have gained attention as an alternative to developing de novo drugs. The potential of using central nervous system (CNS) drugs as anticancer drugs has been explored in several types of human cancers, such as breast and colon cancer, among others. Here, we examine the effect of the CNS drugs sertraline, paroxetine, and chlorpromazine on human squamous carcinoma cells of the bladder (UM-UC-5). After exposing UM-UC-5 cells to increased concentrations of each drug for 48 h, we assessed their metabolic activity using an MTT assay. Based on those results, we calculated cell viability and the half-maximal inhibitory concentration (IC50) values. The results suggest that the CNS drugs were effective against UM-UC-5 in the order of potency of sertraline > chlorpromazine > paroxetine. Interestingly, sertraline was more potent than 5-fluorouracil (5-FU), a widely used anticancer drug. This study demonstrated, for the first time, the promising anticancer activity of CNS drugs on human bladder cancer cells in vitro and supports the repurposing of CNS drugs to improve cancer treatment. Nevertheless, further studies are necessary to understand their mechanism of action and in vivo activity.

Mangifera indica L. kernel ethanol extract inhibits cell viability and proliferation with induction of cell cycle arrest and apoptosis in lung cancer cells

ABSTRACT In this study, we investigated the effects of an ethanolic extract of Mangifera indica L. kernel on the viability and proliferation of human lung cancer cells. We utilized MTT and BrdU cell proliferation assays, morphological assessments, cell cycle analyses, and apoptosis assays to investigate the extract’s effects on lung cancer (A549 and NCI-H292) and normal lung (MRC-5) cells. The extract demonstrated a toxicity toward cancer cells compared to normal cells with dose-dependent anti-proliferative effect on lung cancer cells. The extract also caused differential effects on the cell cycle, inducing G0/G1 arrest and increasing the Sub-G1 population in both lung cancer and normal lung cells. Notably, the extract induced loss of membrane integrity, shrinkage, membrane blebbing, and apoptosis in lung cancer cells, while normal cells exhibited only early apoptosis. Furthermore, the extract exhibited higher toxicity towards NCI-H292 cells, followed by A549 and normal MRC-5 cells in decreasing order of potency. Our results suggest that the ethanolic extract of M. indica L. kernel has significant potential as a novel therapeutic agent for treating lung cancer cells, given its ability to induce apoptosis in cancer cell lines while causing minimal harm to normal cells.

Comparison of the effects of selected aminoglycoside antibiotics on motor behaviors in mice.

Aminoglycoside antibiotics (AGs) can cause neuromuscular blockade and paralysis of skeletal muscles. To compare the paralytic effects of selected AGs on some motor behaviors in mice, 24 male mice were divided into four groups. Each group was given one of AGs (gentamicin, dihydro-streptomycin, apramycin and amikacin) at incremental doses that increased half-logarithmically compared to the therapeutic dose (16.00 mg kg-1). Motor behavioral tests included open field test, inclined plane, horizontal bars, static rods, parallel bars and rotarod. Finally, the data were analyzed using descriptive and analytical statistics. Gentamicin and dihydrostreptomycin at 32.00 times of the therapeutic dose produced complete paralysis of the limbs, respiratory arrest, and even death in some animals. However, apramycin and amikacin did not show significant effects on skeletal muscle and motor behaviors at 32.00 times of the therapeutic dose. After administration of apramycin at 100 times of the therapeutic dose, four out of six mice (66.67%) died from respiratory depression. Amikacin at this dose did not cause animal death, although it caused some changes in motor behaviors with a significant difference in comparison with control values. Gentamicin demonstrated significantly more potent effects on motor behaviors compared to the other AGs. Overall, the order of potency was gentamicin > dihydrostreptomycin > apramycin > amikacin. High doses of AGs could impair the skeletal muscle function and disrupt motor behaviors in mice. Furthermore, the paralytic potency of selected AGs on skeletal muscle was significantly different.

Relaxant Effects of Piperine and Piperlongumine from Piper longum Fruits on Porcine Coronary Artery.

Since ancient times, Piper longum Linn. fruits have been recognized for exhibiting various effects, including the diaphoretic effects linked to enhanced blood flow. Piperine and piperlongumine coexist in Piper longum Linn. fruits, although the cardiovascular effects of both compounds remain elusive. We investigated their action of piperine and piperlongumine in porcine coronary arteries, comparing them to the Ca2+ channel antagonist diltiazem. Piperlongumine, unlike piperine or diltiazem, concentration-dependently inhibited basal contractile tone in endothelium-denuded coronary arteries. All three compounds inhibit tonic contractions induced by high potassium chloride (KCl) concentrations. The order of relaxation potency indexed by the half-maximal effective concentration (EC50) were as follows: diltiazem > piperlongumine > piperine. These effects were not different between endothelium-intact and -denuded preparations. In endothelial-denuded preparations, pretreatment with these compounds not only inhibited KCl-induced tonic contractions attenuated calcium chloride (CaCl2)-induced ones in a Ca2+-free medium. Histamine-induced phasic contractions in a Ca2+-free medium containing intracellular Ca2+ chelator was completely suppressed by selective inositol trisphosphate receptor antagonist and piperlongumine, whereas piperine or diltiazem do not have the same effect. These findings suggest that piperine and piperlongumine similar to diltiazem cause vasorelaxation by inhibiting both KCl- and CaCl2-induced contractions in coronary arteries, possibly through the inhibition of voltage-dependent Ca2+ channels. Piperlongumine inhibits histamine-induced contractions in a Ca2+-free medium, which is associated with the intracellular Ca2+ signaling pathway, suggesting that the relaxant effect of piperlongumine differs from that of piperine.

Assessing the Toxicity of Benzotriazole Ultraviolet Stabilizers to Fishes: Insights into Aryl Hydrocarbon Receptor-Mediated Effects.

Benzotriazole ultraviolet stabilizers (BUVSs) are chemicals used to mitigate UV-induced damage to manufactured goods. Their presence in aquatic environments and biota raises concerns, as certain BUVSs activate the aryl hydrocarbon receptor (AhR), which is linked to adverse effects in fish. However, potencies of BUVSs as AhR agonists and species sensitivities to AhR activation are poorly understood. This study evaluated the toxicity of three BUVSs using embryotoxicity assays. Zebrafish (Danio rerio) embryos exposed to BUVSs by microinjection suffered dose-dependent increases in mortality, with LD50 values of 4772, 11 608, and 56 292 ng/g-egg for UV-P, UV-9, and UV-090, respectively. The potencies and species sensitivities to AhR2 activation by BUVSs were assessed using a luciferase reporter gene assay with COS-7 cells transfected with the AhR2 of zebrafish and eight other fishes. The rank order of potency for activation of the AhR2 from all nine species was UV-P > UV-9 > UV-090. However, AhR2s among species differed in sensitivities to activation by up to 100-fold. An approximate reversed rank order of species sensitivity was observed compared to the rank order of sensitivity to 2,3,7,8-tetrachlorodibenzo[p]dioxin, the prototypical AhR agonist. Despite this, a pre-existing quantitative adverse outcome pathway linking AhR activation to embryo lethality could predict embryotoxicities of BUVSs in zebrafish.

First Full-Length Cloning of Human NaV1.7 in S. Cerevisiae-Based Novel D-Crypt Platform for its High-Scale Production

NaV1.7, a voltage-gated sodium channel, induces chronic pain. Current research on the discovery of inhibitors against NaV1.7 is advancing with the hope of treating chronic pain conditions in patients suffering from various diseases. However, to characterize NaV1.7 and inhibitor interactions, a higher yield of expression is required to obtain sufficient protein. Molecular cloning of hNaV1.7 was done using the homologous recombination method in our novel S. cerevisiae-based D-cryptÔ platform. The platform was designed for the high-yield production of ‘difficult-to-express’ proteins (DTE-Ps) up to 500 L. The changes in the cell membrane potential of hNaV1.7 were determined using a fluorescence resonance energy transfer (FRET) assay with tetracaine (hNaV1.7 inhibitor). Expression analysis of hNaV1.7 showed 2 bands of size 250 and 280 kDa that were absent in untransfected yeast cells. Immunofluorescence images revealed the presence of hNaV1.7 on the membrane of hNaV1.7-expressing yeast cells. Tetracaine exhibited concentration-dependent inhibition of the FRET ratio, with the order of potency (IC50 = 0.46 µM) being approximately the same as previously reported, suggesting the functionality of the channel protein expressed in the D-cryptÔ platform. Cloning of NaV1.7 in the D-cryptÔ platform will help to scale up the production of channel proteins, which will ultimately help in the structural and functional characterization of the binding interactions between toxins and the NaV1.7 channel to identify more specific NaV1.7 inhibitors. HIGHLIGHTS 7 is a voltage-gated sodium channel and induces chronic pain 7 inhibitors can advance the treatment of chronic pain associated with various diseases To characterize interaction of Nav1.7 with its inhibitors, higher yield of the NaV1.7 is required D-crypt is a platform designed for the high-yield production of ‘difficult-to-express’ proteins (DTE-Ps) up to 500 L Successful cloning of NaV1.7 in D-crypt platform suggest that the D-crypt platform is a suitable platform for expressing full-length functionally active hNaV1.7 channel at larger scale. It will further aid in the screening of NaV1.7 inhibitors GRAPHICAL ABSTRACT

Synthesis, characterization, molecular docking and molecular dynamics simulations of novel 2,5-disubstituted-1,3,4-thiadiazole derivatives as potential cholinesterase/monoamine oxidase dual inhibitors for Alzheimer’s disease

Designing multi-targeted drugs (MTD) for Alzheimer’s disease (AD) is now one of the priorities for medicinal chemists, as the disease has a complicated not fully understood pathological nature and the approved mono-targeted drugs only alleviate the symptoms. In this study, the synthesis, spectral analyses and in vitro inhibition activity against cholinesterase (ChE) and monoamine oxidase (MAO) enzymes of a novel series of N-[5-(adamantan-1-yl)-1,3,4-thiadiazol-2-yl]-2-(4-un/substituted) cyclic secondary amino-acetamide/propanamide derivatives were done. Generally, derivatives were more selective against acetylcholinesterase (AChE) and h-MAO-B than butyrylcholinesterase (BChE) and h-MAO-A, respectively. Derivatives 4a, 4b, 3a, 3d and 3b ordered from the most potent to the least displayed significant inhibition against AChE. Also, derivatives 4a, 4b and 3a still maintained their significant inhibition against h-MAO-B in the same potency order, making them dual inhibitors and MTD candidates for AD. Binding interactions with several crucial amino acid residues for activity and selectivity as well as the stability of the most active derivatives-enzyme complex were confirmed utilizing molecular docking and molecular dynamic simulation studies. Communicated by Ramaswamy H. Sarma